BlackRock Health Sciences Trust
BME
Market Cap$579.65M
Close$
$9.77
73% downside
Current Fair Value
73% downsideOvervalued by 73% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $579.65 Million |
|---|---|
| Enterprise Value | $579.58 Million |
| Dividend Yield | $2.56 (6.14866490257397%) |
| Earnings per Share | $1.44 |
| Beta | 0.67 |
| Outstanding Shares | 13,943,973 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 8.24 |
|---|---|
| PEG | 3.59 |
| Price to Sales | 18.1 |
| Price to Book Ratio | 0.66 |
| Enterprise Value to Revenue | 15.89 |
| Enterprise Value to EBIT | 14.74 |
| Enterprise Value to Net Income | 7 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About BlackRock Health Sciences Trust
CEO: John Perlowski BlackRock Health Sciences Trust’s (BME) (the 'Trust') investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment ob...